Thus, targeting brain insulin signaling through the administration of drugs that have already been previously approved for the treatment of diabetes mellitus, such as insulin and drugs that improve insulin sensitivity, could expedite their development for the treatment of AD (Chen et al., 2016). Here, INS is linked to Alzheimer disease.